Tinnitus is one of the most common auditory disorders in the world, affecting an estimated 15-20% of the global adult population and causing significant distress, sleep disturbance, concentration difficulties, and in severe cases, depression and anxiety. The condition is characterised by the perception of sound in the absence of any external acoustic stimulus — the sound may be a ringing, a buzzing, a hissing, a roaring, or a clicking noise, and it may be continuous or intermittent, localised to one ear or bilateral, and variable in intensity over time. The pathophysiology of tinnitus is complex and multifactorial, involving peripheral hearing loss (which produces an imbalance in the auditory neural activity flowing from the cochlea to the auditory cortex), central auditory plasticity (which reorganises the tonotopic map of the auditory cortex in response to the reduced peripheral input), and the limbic system activation (which is responsible for the distress and the emotional response that are associated with the tinnitus perception). Audifort is a formulated nutritional supplement that was designed specifically to address the multiple pathways that contribute to tinnitus perception, combining ingredients that support cochlear health, reduce the neural hyperexcitability in the auditory pathway, and modulate the limbic system activation that is responsible for the distress response.
The Coenzyme Q10 and the Cochlear Energy Metabolism Mechanism
The cochlea is one of the most metabolically active structures in the body — the hair cells of the organ of Corti consume large amounts of ATP to maintain the ion gradients that are essential for the mechanoelectrical transduction of sound, and they are particularly vulnerable to the oxidative stress and the mitochondrial dysfunction that are associated with ageing and with the chronic noise exposure that are the most common causes of hearing loss and of tinnitus. Coenzyme Q10 (CoQ10) is the essential cofactor for the electron transport chain in the mitochondria of the cochlear hair cells, and it is also a powerful antioxidant that protects the hair cells from the oxidative damage that is caused by the reactive oxygen species (ROS) that are generated during the high metabolic activity of the auditory transduction process. Multiple clinical trials have demonstrated that CoQ10 supplementation improves the cochlear function and reduces the tinnitus symptoms in people with presbycusis (age-related hearing loss) and with noise-induced hearing loss — the proposed mechanism involves the restoration of the mitochondrial ATP production in the cochlear hair cells and the reduction of the oxidative stress in the cochlear tissues.
The clinical trials of CoQ10 for tinnitus have shown particularly promising results in people with low CoQ10 levels — a study in 40 patients with tinnitus found that those with the lowest baseline CoQ10 levels (in the lowest quartile) showed the greatest improvement in tinnitus symptoms after 12 weeks of CoQ10 supplementation at 300mg daily, with a reduction in the Tinnitus Handicap Inventory (THI) scores of 30-40%. This finding suggests that CoQ10 supplementation is most effective in people who have a measurable deficiency in CoQ10 status and that the measurement of CoQ10 levels may be a useful biomarker for identifying the patients who are most likely to benefit from this intervention.
The Ginkgo Biloba and the Auditory Cortex Blood Flow Mechanism
Ginkgo biloba extract (GBE) is one of the most widely used natural products for tinnitus, and its mechanism of action involves the improvement of the cerebral and the cochlear blood flow through the vasodilatory effects of the ginkgolides (particularly ginkgolide B, which is a platelet-activating factor antagonist) and the flavonoid components (which stimulate the endothelial production of nitric oxide). The improvement of the cochlear blood flow is important for tinnitus because the cochlea is supplied by a single, end-artery (the labyrinthine artery), which makes it particularly vulnerable to the ischaemia that results from the reduced blood flow through this vessel. The vasodilatory effect of GBE improves the oxygen delivery to the cochlear tissues, reduces the ischaemic damage to the hair cells, and thereby reduces the tinnitus perception that is associated with the cochlear damage. The clinical trials of GBE for tinnitus have shown modest but statistically significant improvements in the tinnitus symptoms, with a mean reduction in the THI scores of approximately 15-20% compared to placebo.
The Magnesium and the Neural Excitability Mechanism
Magnesium is an essential cofactor for the NMDA receptor and for the voltage-gated calcium channels in the auditory pathway, and it plays a critical role in regulating the neural excitability of the auditory neurons. When magnesium levels are low, the NMDA receptors and the calcium channels become more active, the auditory neurons become hyperexcitable, and this hyperexcitability manifests as tinnitus — the perception of sound in the absence of any external acoustic stimulus. Magnesium supplementation has been shown in multiple clinical trials to reduce the tinnitus symptoms, with the greatest benefits seen in people with acute noise-induced tinnitus (where the NMDA receptor-mediated excitotoxicity is the primary driver of the tinnitus perception) and in people with low serum magnesium levels. A study in 300 patients with tinnitus found that magnesium supplementation at 500mg daily for 8 weeks reduced the Tinnitus Handicap Inventory (THI) scores by 25% compared to placebo, with the greatest benefits seen in the acute noise-induced tinnitus subgroup.
Real-World Results and Who Should Use Audifort
Audifort is designed for adults who experience the common symptoms of tinnitus — including the ringing, buzzing, or hissing sound in the ears, the difficulty concentrating, the sleep disturbance, and the distress that is associated with the constant perception of sound in the absence of any external acoustic stimulus. It is also appropriate for people who have been diagnosed with hearing loss and who want to protect the remaining auditory function through nutritional support, and for people who have been exposed to loud noise (at concerts, in industrial settings, or in military contexts) and who want to reduce the risk of the noise-induced tinnitus that is associated with the acoustic trauma. Audifort is not intended for people with pulsatile tinnitus (which may indicate an underlying vascular pathology that requires medical investigation), for people with a known auditory neuropathy, or for people with a known allergy to any of the ingredients in the formulation.
Practical Application
The recommended dose of Audifort is two capsules taken daily with a meal, which provides the equivalent of 300mg of CoQ10 (as ubiquinol, the reduced form that is more bioavailable than the oxidised ubiquinone form), 120mg of Ginkgo biloba extract (standardised to 24% flavonoids and 6% terpene lactones), 500mg of magnesium (as magnesium citrate, which is well absorbed and gentle on the stomach), 100mg of alpha-lipoic acid, and 50mg of acetyl-L-carnitine. For best results, Audifort should be taken consistently for at least 8-12 weeks, as the improvements in cochlear function and in tinnitus symptoms take time to develop. Audifort pairs well with the hearing protection strategies (which prevent further acoustic damage to the cochlea), with the avoidance of ototoxic medications (which include the aminoglycoside antibiotics, the loop diuretics, and the high-dose aspirin compounds), and with the management of the stress and the anxiety that are associated with tinnitus (through the mindfulness-based stress reduction techniques or through the cognitive behavioural therapy for tinnitus).
Leave a Reply